https://www.entrepreneur.com/en-au/news-and-trends/israeli-companies-are-leading-the-global-biotechIn an attempt to become self-reliant, Israel invested in infrastructure, education, and technology to empower innovative leaders and field experts to lead the charge in their respective industries-charge/434706 read more
Tel Aviv, Israel, July 18, 2022 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that Polyrizon Ltd. (“Polyrizon”), an Israeli biotech company that specializes in innovative intranasal products in which Medigus owns 37.03%,
Calgary, Alberta–(Newsfile Corp. – July 25, 2022) – NurExone Biologic Inc. (TSXV: NRX) (“NurExone” or the “Company”), a biopharmaceutical company developing biologically-guided exosome therapy for patients with traumatic spinal injuries and other Central Nervous System (“CNS”) indications, is pleased to announce that it will showcase a poster presentation at the
Israeli biotech Polyrizon is collaborating with NurExone Biologic for intranasal administration of a therapy for spinal cord injuries (SCI). Under the agreement, Polyrizon — in which Medigus (NASDAQ:MDGS) owns a 37.03% stake — will use its Trap and Target platform to develop formulations, conduct analytical development and produce technical batches of a
The company is developing a novel, non-invasive, bio-guided treatment to restore function of patients with acute spinal cord injuries. read more
SHARE TWEET SHARE EMAILThe Israeli BioTech company tackling SCI injury treatment recently began trading on the TSXV Approximately 17,700 new spinal cord injuries (SCI) take place each year just in the US alone, most of which are the result of vehicle, work and sporting accidents and falls. Calculating the impact
An estimated 17,700 new spinal cord injuries (SCI)occur each year in the United States alone, most of which are the result of vehicle, work and sporting accidents and falls. Calculating the impact of spinal cord injuries on people worldwide requires a broader sample, but the World Health Organization (WHO) states
Within the biotech sector, the spinal cord injury (SCI) segment stands out as an enormous market with significant unmet needs. The World Health Organization estimates between 250,000 and 500,000 people around the world suffer from SCI each year. It’s also been estimated that around 291,000 people in the US currently
In 2021, Israeli businesses filed for a record number of IPOs on both U.S. and Israeli stock exchanges. Although IPOs are expected to be slower this year due to recent geopolitical and economic turbulence, the number of Israeli companies entering public markets remains extraordinary. Here are three companies we are
Hear from the CEO of NurExone Biologic Ltd, Israel’s promising new start-up which aims to utilize innovative Exosome-based technology and smart delivery platforms in order to revolutionize the way spinal cord injury (SCI) is treated around the world read more
